Prospects for the application of mesenchymal stem cells in Alzheimer's disease treatment

F Chakari-Khiavi, S Dolati, A Chakari-Khiavi… - Life sciences, 2019 - Elsevier
Alzheimer's disease (AD) as a dementia and neurodegenerative disease, is mostly
prevalent among people more than 65 years. AD is mostly manifested in the form of …

Mesenchymal stem cell therapy and Alzheimer's disease: current status and future perspectives

J Kim, Y Lee, S Lee, K Kim, M Song… - Journal of Alzheimer's …, 2020 - content.iospress.com
Alzheimer's disease (AD) is the most common progressive neurodegenerative disease
worldwide, but its cause remains unclear. Although a few drugs can provide temporary and …

Mesenchymal stromal cells for the treatment of Alzheimer's disease: Strategies and limitations

S Regmi, DD Liu, M Shen, BD Kevadiya… - Frontiers in Molecular …, 2022 - frontiersin.org
Alzheimer's disease (AD) is a major cause of age-related dementia and is characterized by
progressive brain damage that gradually destroys memory and the ability to learn, which …

Mesenchymal stem cell therapies for Alzheimer's disease: preclinical studies

X Zhao, D Li, L Zhang, Y Niu, W Wang, B Niu - Metabolic Brain Disease, 2021 - Springer
Alzheimer's disease (AD) is a chronic, progressive, and fatal neurodegenerative disorder
that is characterized by memory failure, cognitive impairment, as well as behavioral and …

The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms

G Turgeman - Neural regeneration research, 2015 - journals.lww.com
Mesenchymal stem cells (MSCs) are pluripotent stem cells isolated from various tissues, but
mostly from bone marrow, adipose tissue, and umbilical cord blood. Well known for their …

Stem cells as a promising therapeutic approach for Alzheimer's disease: a review

GI Fouad - Bulletin of the National Research Centre, 2019 - Springer
Alzheimer's disease (AD) is a neurodegenerative disorder that impairs memory formation
and disrupts neurocognitive function. This neuropathy is characterized by neural loss …

[HTML][HTML] Stem cell therapy for Alzheimer's disease

XY Liu, LP Yang, L Zhao - World journal of stem cells, 2020 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by
memory loss and cognitive impairment. It is caused by synaptic failure and excessive …

[HTML][HTML] Advances in stem cell therapy in Alzheimer's disease: a comprehensive clinical trial review

N Karvelas, S Bennett, G Politis, NI Kouris… - Stem cell …, 2022 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the most common type of dementia responsible for more than
121,499 deaths from AD in 2019 making AD the sixth-leading cause in the United States. AD …

[HTML][HTML] Manipulated mesenchymal stem cells applications in neurodegenerative diseases

S omid Sadatpoor, Z Salehi… - … journal of stem cells, 2020 - synapse.koreamed.org
Mesenchymal stem cells (MSCs) are multipotent stem cells that have multilinear
differentiation and self-renewal abilities. These cells are immune-privileged as they express …

Potential of neural stem cell‐based therapies for A lzheimer's disease

XY Li, XJ Bao, RZ Wang - Journal of Neuroscience Research, 2015 - Wiley Online Library
Alzheimer's disease (AD), known to be a leading cause of dementia that causes heavy
social and financial burdens worldwide, is characterized by progressive loss of neurons and …